WIRKSAME MRNA-IMPFSTOFFE

European patent · EP3668522 · Deleted

Register entry

Publication number
EP3668522
Application number
EP18846700
Kind
European patent with effect for Switzerland and Liechtenstein
Status
Deleted
Specification
Granted
Filed
Aug 17, 2018
Published
Jun 24, 2020
Granted
Sep 11, 2024
Deleted
Mar 24, 2026
Reason
Annual fee unpaid
IPC classes
A61K 31/7088 (2006.01)
A61K 39/145 (2006.01)
A61K 9/51 (2006.01)
G01N 33/50 (2006.01)
A61P 31/16 (2006.01)
A61K 47/69 (2017.01)
Priority
US 201762547665 P 18.08.2017
US 201762560548 P 19.09.2017
PCT application
PCT/US2018/046974 17.08.2018
PCT publication
WO2019/036670 21.02.2019
Filing language
English
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Mar 24, 2026

    Deleted, fee unpaid

    Status of protective title
    Active → Cancelled
    Cancellation date
    24.03.2026
    Cause for cancellation
    Non-payment of renewal fee

    Published in Swissreg on 24.03.2026

  2. Jul 23, 2025

    Change

    Published in Swissreg on 23.07.2025

  3. Sep 11, 2024

    Granted

    Specification status
    Non-published patent application → Granted patent
    Status of protective title
    Initiated → Active

    Published in Swissreg on 11.09.2024

Parties

Holder

ModernaTx, Inc.

ModernaTX, Inc.

325 Binney Street, Cambridge, MA 02142, US

Inventor

HOGE, Stephen

Cambridge, MA 02139, US

CIARAMELLA, Giuseppe

Sudbury, MA 01776, US

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.